Acute Cyanide Poisoning: Novel Approaches for Intervention in the Prehospital and Hospital Setting CME

Marc Eckstein, MD, MPH, FACEP, Chair; Stephen W. Borron, MD, MS, FACEP, FACMT; Jeffrey Scott Guy, MD, FACS, EMT-P Author Information and Disclosures

Release Date: May 30, 2008; Valid for credit through May 30, 2009

Credits Available
Physicians - maximum of 2.0 AMA PRA Category 1 Credit(s)™ for physicians

This CME activity is based on transcripts and slides of presentations as delivered by the faculty at the "Acute Cyanide Poisoning: Novel Approaches for Intervention in the Prehospital and Hospital Setting" symposium held at The Westin Seattle Grand Ballroom III in Seattle, Washington, on October 9, 2007.

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the educational content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Postgraduate Institute of Medicine (PIM)
Dey
Learning Objectives
Upon completion of this activity, participants should be able to:
  1. Identify the historical implications, mechanism of action of cyanide, and pathophysiology of cyanide toxicity.
  2. Name the various environmental sources of cyanide and the present diagnostic criteria to determine cyanide poisoning.
  3. Describe the clinical signs and symptoms of acute cyanide poisoning and its impact on society.
  4. Outline the barriers to proper management of cyanide poisoning in the prehospital and hospital settings.
  5. List the present pharmacologic treatments of cyanide poisoning and their adverse effects.
  6. Compare the new and improved therapeutic regimens approved to treat cyanide poisoning in the prehospital and hospital settings.
Author Disclosures
Stephen W. Borron, MD, MS, FACEP, FACMT
Disclosure: Consultant: Dey, L.P.; Fees for Non-CME Services: Dey, L.P.; Contracted Research: EMD Pharmaceuticals, Inc.

Marc Eckstein, MD, MPH, FACEP
Disclosure: Consultant: Dey, L.P.

Jeffrey Scott Guy, MD, FACS, EMT-P
Disclosure: No financial interest/relationships with financial interests relating to the topic of this activity.

The planners and managers of this CME activity reported no financial interest/relationships with financial interests relating to the topic of this activity.
 
Postgraduate Institute for Medicine
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and CME Fission. PIM is accredited by the ACCME to provide continuing medical education for physicians.

Postgraduate Institute for Medicine designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.